URO-902

N/A

Report date: 2024/12/26 17:50:48

Base Information

Drug NameURO-902
Drug Alias NamehMaxiK gene therapyhMaxi-K - Ion Channel InnovationsIon Channel TherapyURO-902
ClassificationCell and gene therapy > Gene therapy > Plasmid
Mechanisms of ActionCalcium-activated potassium channel subunit alpha-1 gene transference
TargetsCalcium-activated potassium channel subunit alpha-1
Therapy Area/IndicationsUrinary IncontinenceUrinary Bladder, OveractiveErectile Dysfunction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesKuwait
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIon Channel Innovations
China Registration ClassN/A

Develop Information

Active CompaniesUrovant Sciences Gmbh
Inactive CompaniesIon Channel Innovations
Active IndicationsUrinary IncontinenceUrinary Bladder, Overactive
Inactive IndicationsErectile Dysfunction

Other Information

ATC CodeN/A
Related LinksN/A